> top > docs > PubMed:1493333 > annotations

PubMed:1493333 JSONTXT

Annnotations TAB JSON ListView MergeView

MyTest

Id Subject Object Predicate Lexical cue
T6 1352-1359 Binding denotes binding
T1 1363-1378 Protein denotes I kappa B/MAD-3
T2 1382-1396 Protein denotes NF-kappa B p65
T3 1423-1437 Protein denotes NF-kappa B p65
T4 1447-1454 Cell_part denotes nucleus
T5 1462-1471 Cell_part denotes cytoplasm
T7 1414-1422 Localization denotes retarget
T8 1400-1410 Pos_regulation denotes sufficient
R1 T7 T3 hasTheme retarget,NF-kappa B p65
R2 T7 T4 fromLoc retarget,nucleus
R3 T7 T5 toLoc retarget,cytoplasm
R4 T1 T6 hasTheme I kappa B/MAD-3,binding
R5 T1 T2 hasTheme I kappa B/MAD-3,NF-kappa B p65
R6 T8 T7 hasTheme sufficient,retarget
R7 T8 T1 hasCause sufficient,I kappa B/MAD-3

relna

Id Subject Object Predicate Lexical cue
T1 10-15 Protein denotes MAD-3
T2 57-71 DNA denotes NF-kappa B p65
T3 123-137 DNA denotes NF-kappa B p65
T4 263-277 DNA denotes NF-kappa B p65
T5 282-296 DNA denotes NF-kappa B p50
T6 394-408 DNA denotes NF-kappa B p65
T7 585-599 DNA denotes NF-kappa B p50
T8 842-847 Protein denotes MAD-3
T9 867-881 DNA denotes NF-kappa B p65
T10 1373-1378 Protein denotes MAD-3
T11 1382-1396 DNA denotes NF-kappa B p65
T12 1423-1437 DNA denotes NF-kappa B p65
T13 1579-1593 DNA denotes NF-kappa B p65
T14 1635-1647 DNA denotes MAD-3, and 4
T15 1674-1688 DNA denotes NF-kappa B p65
T16 1807-1821 DNA denotes NF-kappa B p65
T17 1944-1958 DNA denotes NF-kappa B p65
T18 2057-2062 Protein denotes MAD-3
T19 2130-2135 Protein denotes MAD-3
T20 2154-2168 DNA denotes NF-kappa B p50
T21 2231-2245 DNA denotes NF-kappa B p50
T22 2424-2438 DNA denotes NF-kappa B p65
R0 T10 T11 linked MAD-3,NF-kappa B p65
R1 T19 T20 linked MAD-3,NF-kappa B p50

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 1274-1290 HP_0002721 denotes immunodeficiency

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 0-15 protein denotes I kappa B/MAD-3
T2 57-71 protein denotes NF-kappa B p65
T3 89-111 protein denotes transactivation domain
T4 123-137 protein denotes NF-kappa B p65
T5 182-221 protein denotes NF-kappa B transcription factor complex
T6 241-261 protein denotes DNA binding subunits
T7 263-277 protein denotes NF-kappa B p65
T8 282-296 protein denotes NF-kappa B p50
T9 366-388 protein denotes v-rel oncogene product
T10 394-416 protein denotes NF-kappa B p65 subunit
T11 542-552 protein denotes NF-kappa B
T12 585-599 protein denotes NF-kappa B p50
T13 723-732 protein denotes I kappa B
T14 817-827 protein denotes NF-kappa B
T15 832-847 protein denotes I kappa B/MAD-3
T16 861-889 protein denotes human NF-kappa B p65 mutants
T17 947-956 protein denotes I kappa B
T18 982-991 protein denotes I kappa B
T19 1026-1046 protein denotes transcription factor
T20 1109-1131 protein denotes NF-kappa B p65 mutants
T21 1159-1174 protein denotes I kappa B/MAD-3
T22 1195-1209 protein denotes NF-kappa B p65
T23 1268-1320 DNA denotes human immunodeficiency virus type 1 kappa B enhancer
T24 1324-1343 cell_type denotes human T lymphocytes
T25 1363-1378 protein denotes I kappa B/MAD-3
T26 1382-1396 protein denotes NF-kappa B p65
T27 1423-1437 protein denotes NF-kappa B p65
T28 1556-1575 protein denotes Rel homology domain
T29 1579-1593 protein denotes NF-kappa B p65
T30 1625-1640 protein denotes I kappa B/MAD-3
T31 1660-1670 protein denotes C-terminus
T32 1674-1688 protein denotes NF-kappa B p65
T33 1774-1783 protein denotes I kappa B
T34 1807-1821 protein denotes NF-kappa B p65
T35 1918-1940 protein denotes transactivation domain
T36 1944-1958 protein denotes NF-kappa B p65
T37 2047-2062 protein denotes I kappa B/MAD-3
T38 2120-2135 protein denotes I kappa B/MAD-3
T39 2154-2168 protein denotes NF-kappa B p50
T40 2231-2245 protein denotes NF-kappa B p50
T41 2368-2385 protein denotes C-terminal domain
T42 2424-2438 protein denotes NF-kappa B p65

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-15 NP denotes I kappa B/MAD-3
C3 57-71 NP denotes NF-kappa B p65
C2 22-71 NP denotes the nuclear localization signal of NF-kappa B p65
C4 89-111 NP denotes transactivation domain
C6 123-137 NP denotes NF-kappa B p65
C5 123-149 NP denotes NF-kappa B p65 DNA binding
C8 182-213 NP denotes NF-kappa B transcription factor
C7 178-221 NP denotes the NF-kappa B transcription factor complex
C9 237-261 NP denotes two DNA binding subunits
C11 263-277 NP denotes NF-kappa B p65
C12 282-296 NP denotes NF-kappa B p50
C10 263-296 NP denotes NF-kappa B p65 and NF-kappa B p50
C13 306-311 NP denotes which
C14 390-416 NP denotes The NF-kappa B p65 subunit
C15 458-470 NP denotes this complex
C17 542-552 NP denotes NF-kappa B
C16 515-552 NP denotes a cytoplasmic inhibitor of NF-kappa B
C18 561-570 NP denotes I kappa B
C19 585-599 NP denotes NF-kappa B p50
C20 723-732 NP denotes I kappa B
C21 817-827 NP denotes NF-kappa B
C22 832-847 NP denotes I kappa B/MAD-3
C24 867-881 NP denotes NF-kappa B p65
C23 849-889 NP denotes a series of human NF-kappa B p65 mutants
C25 1021-1046 NP denotes this transcription factor
C27 1109-1123 NP denotes NF-kappa B p65
C26 1103-1131 NP denotes these NF-kappa B p65 mutants
C28 1159-1174 NP denotes I kappa B/MAD-3
C29 1363-1378 NP denotes I kappa B/MAD-3
C30 1382-1396 NP denotes NF-kappa B p65
C31 1423-1437 NP denotes NF-kappa B p65
C32 1443-1454 NP denotes the nucleus
C33 1458-1471 NP denotes the cytoplasm
C35 1579-1593 NP denotes NF-kappa B p65
C34 1498-1593 NP denotes the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65
C36 1603-1606 NP denotes its
C37 1625-1640 NP denotes I kappa B/MAD-3
C38 1674-1688 NP denotes NF-kappa B p65
C39 1700-1703 NP denotes its
C40 1742-1751 NP denotes sequences
C41 1752-1756 NP denotes that
C43 1807-1821 NP denotes NF-kappa B p65
C42 1807-1842 NP denotes NF-kappa B p65 DNA binding activity
C44 1882-1913 NP denotes the nuclear localization signal
C46 1944-1958 NP denotes NF-kappa B p65
C45 1918-1958 NP denotes transactivation domain of NF-kappa B p65
C47 1970-1988 NP denotes a bipartite system
C48 1989-1993 NP denotes that
C49 2047-2062 NP denotes I kappa B/MAD-3
C50 2120-2135 NP denotes I kappa B/MAD-3
C51 2154-2168 NP denotes NF-kappa B p50
C52 2170-2186 NP denotes This interaction
C53 2204-2206 NP denotes it
C54 2231-2245 NP denotes NF-kappa B p50
C55 2251-2262 NP denotes the nucleus
C56 2266-2279 NP denotes the cytoplasm
C57 2357-2385 NP denotes the unique C-terminal domain
C58 2386-2390 NP denotes that
C59 2408-2412 NP denotes that
C60 2424-2438 NP denotes NF-kappa B p65
R1 C6 C3 coref-ident NF-kappa B p65,NF-kappa B p65
R2 C11 C6 coref-ident NF-kappa B p65,NF-kappa B p65
R3 C10 C9 coref-appos NF-kappa B p65 and NF-kappa B p50,two DNA binding subunits
R4 C13 C9 coref-relat which,two DNA binding subunits
R5 C14 C11 coref-ident The NF-kappa B p65 subunit,NF-kappa B p65
R6 C15 C7 coref-ident this complex,the NF-kappa B transcription factor complex
R7 C17 C8 coref-ident NF-kappa B,NF-kappa B transcription factor
R8 C18 C16 coref-ident I kappa B,a cytoplasmic inhibitor of NF-kappa B
R9 C19 C12 coref-ident NF-kappa B p50,NF-kappa B p50
R10 C20 C18 coref-ident I kappa B,I kappa B
R11 C21 C17 coref-ident NF-kappa B,NF-kappa B
R12 C22 C1 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R13 C24 C14 coref-ident NF-kappa B p65,The NF-kappa B p65 subunit
R14 C25 C21 coref-ident this transcription factor,NF-kappa B
R15 C27 C24 coref-ident NF-kappa B p65,NF-kappa B p65
R16 C26 C23 coref-ident these NF-kappa B p65 mutants,a series of human NF-kappa B p65 mutants
R17 C28 C22 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R18 C29 C28 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R19 C30 C27 coref-ident NF-kappa B p65,NF-kappa B p65
R20 C31 C30 coref-ident NF-kappa B p65,NF-kappa B p65
R21 C35 C31 coref-ident NF-kappa B p65,NF-kappa B p65
R22 C34 C2 coref-other the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65,the nuclear localization signal of NF-kappa B p65
R23 C36 C35 coref-pron its,NF-kappa B p65
R24 C37 C29 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R25 C38 C35 coref-ident NF-kappa B p65,NF-kappa B p65
R26 C39 C38 coref-pron its,NF-kappa B p65
R27 C41 C40 coref-relat that,sequences
R28 C43 C38 coref-ident NF-kappa B p65,NF-kappa B p65
R29 C42 C5 coref-ident NF-kappa B p65 DNA binding activity,NF-kappa B p65 DNA binding
R30 C44 C34 coref-ident the nuclear localization signal,the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65
R31 C46 C43 coref-ident NF-kappa B p65,NF-kappa B p65
R32 C45 C4 coref-ident transactivation domain of NF-kappa B p65,transactivation domain
R33 C48 C47 coref-relat that,a bipartite system
R34 C49 C37 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R35 C50 C49 coref-ident I kappa B/MAD-3,I kappa B/MAD-3
R36 C51 C19 coref-ident NF-kappa B p50,NF-kappa B p50
R37 C53 C52 coref-pron it,This interaction
R38 C54 C51 coref-ident NF-kappa B p50,NF-kappa B p50
R39 C55 C32 coref-ident the nucleus,the nucleus
R40 C56 C33 coref-ident the cytoplasm,the cytoplasm
R41 C58 C57 coref-relat that,the unique C-terminal domain
R42 C59 C57 coref-pron that,the unique C-terminal domain
R43 C60 C46 coref-ident NF-kappa B p65,NF-kappa B p65

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-150 Sentence denotes I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
S2 151-389 Sentence denotes The active nuclear form of the NF-kappa B transcription factor complex is composed of two DNA binding subunits, NF-kappa B p65 and NF-kappa B p50, both of which share extensive N-terminal sequence homology with the v-rel oncogene product.
S3 390-571 Sentence denotes The NF-kappa B p65 subunit provides the transactivation activity in this complex and serves as an intracellular receptor for a cytoplasmic inhibitor of NF-kappa B, termed I kappa B.
S4 572-733 Sentence denotes In contrast, NF-kappa B p50 alone fails to stimulate kappa B-directed transcription, and based on prior in vitro studies, is not directly regulated by I kappa B.
S5 734-1047 Sentence denotes To investigate the molecular basis for the critical regulatory interaction between NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B-mediated inhibition, and I kappa B-induced nuclear exclusion of this transcription factor.
S6 1048-1843 Sentence denotes Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.
S7 1844-2063 Sentence denotes Together, these findings suggest that the nuclear localization signal and transactivation domain of NF-kappa B p65 constitute a bipartite system that is critically involved in the inhibitory function of I kappa B/MAD-3.
S8 2064-2169 Sentence denotes Unexpectedly, our in vivo studies also demonstrate that I kappa B/MAD-3 binds directly to NF-kappa B p50.
S9 2170-2280 Sentence denotes This interaction is functional as it leads to retargeting of NF-kappa B p50 from the nucleus to the cytoplasm.
S10 2281-2439 Sentence denotes However, no loss of DNA binding activity is observed, presumably reflecting the unique C-terminal domain that is distinct from that present in NF-kappa B p65.

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-15 protein_molecule denotes I kappa B/MAD-3
T2 57-71 protein_subunit denotes NF-kappa B p65
T3 89-111 protein_domain_or_region denotes transactivation domain
T4 123-137 protein_subunit denotes NF-kappa B p65
T5 182-221 protein_complex denotes NF-kappa B transcription factor complex
T6 241-261 protein_subunit denotes DNA binding subunits
T7 263-277 protein_subunit denotes NF-kappa B p65
T8 282-296 protein_subunit denotes NF-kappa B p50
T9 328-356 other_name denotes N-terminal sequence homology
T10 366-388 protein_molecule denotes v-rel oncogene product
T11 394-408 protein_subunit denotes NF-kappa B p65
T12 430-454 other_name denotes transactivation activity
T13 517-538 other_name denotes cytoplasmic inhibitor
T14 542-552 protein_molecule denotes NF-kappa B
T15 585-599 protein_subunit denotes NF-kappa B p50
T16 625-655 other_name denotes kappa B-directed transcription
T17 723-732 protein_molecule denotes I kappa B
T18 817-827 protein_molecule denotes NF-kappa B
T19 832-847 protein_molecule denotes I kappa B/MAD-3
T20 861-866 protein_family_or_group denotes human
T21 867-881 protein_subunit denotes NF-kappa B p65
T22 947-956 protein_molecule denotes I kappa B
T23 982-991 protein_molecule denotes I kappa B
T24 1026-1046 protein_family_or_group denotes transcription factor
T25 1109-1131 protein_family_or_group denotes NF-kappa B p65 mutants
T26 1159-1174 protein_molecule denotes I kappa B/MAD-3
T27 1195-1209 protein_subunit denotes NF-kappa B p65
T28 1268-1303 virus denotes human immunodeficiency virus type 1
T29 1324-1343 cell_type denotes human T lymphocytes
T30 1363-1378 protein_molecule denotes I kappa B/MAD-3
T31 1382-1396 protein_subunit denotes NF-kappa B p65
T32 1423-1437 protein_subunit denotes NF-kappa B p65
T33 1447-1454 cell_component denotes nucleus
T34 1462-1471 cell_component denotes cytoplasm
T35 1556-1575 protein_domain_or_region denotes Rel homology domain
T36 1579-1593 protein_subunit denotes NF-kappa B p65
T37 1625-1640 protein_molecule denotes I kappa B/MAD-3
T38 1660-1670 protein_domain_or_region denotes C-terminus
T39 1674-1688 protein_subunit denotes NF-kappa B p65
T40 1774-1783 protein_molecule denotes I kappa B
T41 1807-1821 protein_subunit denotes NF-kappa B p65
T42 1918-1940 protein_domain_or_region denotes transactivation domain
T43 1944-1958 protein_subunit denotes NF-kappa B p65
T44 2047-2062 protein_molecule denotes I kappa B/MAD-3
T45 2120-2135 protein_molecule denotes I kappa B/MAD-3
T46 2154-2168 protein_subunit denotes NF-kappa B p50
T47 2231-2245 protein_subunit denotes NF-kappa B p50
T48 2255-2262 cell_component denotes nucleus
T49 2270-2279 cell_component denotes cytoplasm
T50 2301-2321 other_name denotes DNA binding activity
T51 2368-2385 protein_domain_or_region denotes C-terminal domain
T52 2424-2438 protein_subunit denotes NF-kappa B p65

bionlp-st-gro-2013-training

Id Subject Object Predicate Lexical cue
T47 1324-1329 Eukaryote denotes human
T48 1330-1343 Cell denotes T lymphocytes
T1 0-15 Protein denotes I kappa B/MAD-3
T2 57-71 ProteinSubunit denotes NF-kappa B p65
T3 89-111 ProteinDomain denotes transactivation domain
T5 123-137 ProteinSubunit denotes NF-kappa B p65
T6 138-141 DNA denotes DNA
T8 182-192 TranscriptionFactorComplex denotes NF-kappa B
T9 193-221 TranscriptionFactorComplex denotes transcription factor complex
T10 241-244 DNA denotes DNA
T12 253-261 ProteinSubunit denotes subunits
T13 263-277 ProteinSubunit denotes NF-kappa B p65
T14 282-296 ProteinSubunit denotes NF-kappa B p50
T15 366-380 Gene denotes v-rel oncogene
T16 381-388 GeneProduct denotes product
T17 394-408 ProteinSubunit denotes NF-kappa B p65
T18 458-470 TranscriptionFactorComplex denotes this complex
T19 517-528 CellComponent denotes cytoplasmic
T21 542-552 TranscriptionFactorComplex denotes NF-kappa B
T22 561-570 Protein denotes I kappa B
T24 817-827 TranscriptionFactorComplex denotes NF-kappa B
T25 832-847 Protein denotes I kappa B/MAD-3
T26 861-866 Eukaryote denotes human
T27 867-889 MutantProtein denotes NF-kappa B p65 mutants
T28 934-937 DNA denotes DNA
T30 947-956 Protein denotes I kappa B
T33 982-991 Protein denotes I kappa B
T35 1000-1007 Nucleus denotes nuclear
T37 1026-1046 TranscriptionFactor denotes transcription factor
T38 1109-1131 MutantProtein denotes NF-kappa B p65 mutants
T39 1159-1174 Protein denotes I kappa B/MAD-3
T41 1195-1209 ProteinSubunit denotes NF-kappa B p65
T45 1268-1303 Virus denotes human immunodeficiency virus type 1
T46 1304-1320 Enhancer denotes kappa B enhancer
T50 1363-1378 Protein denotes I kappa B/MAD-3
T51 1382-1396 ProteinSubunit denotes NF-kappa B p65
T53 1423-1437 ProteinSubunit denotes NF-kappa B p65
T54 1447-1454 Nucleus denotes nucleus
T55 1462-1471 CellComponent denotes cytoplasm
T56 1556-1559 GeneProduct denotes Rel
T57 1560-1575 ProteinDomain denotes homology domain
T58 1579-1593 ProteinSubunit denotes NF-kappa B p65
T59 1625-1640 Protein denotes I kappa B/MAD-3
T60 1660-1670 ProteinDomain denotes C-terminus
T61 1674-1688 ProteinSubunit denotes NF-kappa B p65
T63 1708-1715 Nucleus denotes nuclear
T65 1742-1751 Sequence denotes sequences
T66 1774-1783 Protein denotes I kappa B
T69 1807-1821 ProteinSubunit denotes NF-kappa B p65
T70 1822-1825 DNA denotes DNA
T72 1918-1940 ProteinDomain denotes transactivation domain
T73 1944-1958 ProteinSubunit denotes NF-kappa B p65
T74 2024-2043 Function denotes inhibitory function
T75 2047-2062 Protein denotes I kappa B/MAD-3
T76 2120-2135 Protein denotes I kappa B/MAD-3
T78 2154-2168 ProteinSubunit denotes NF-kappa B p50
T81 2231-2245 ProteinSubunit denotes NF-kappa B p50
T82 2255-2262 Nucleus denotes nucleus
T83 2270-2279 CellComponent denotes cytoplasm
T84 2379-2385 ProteinDomain denotes domain
T85 2424-2438 ProteinSubunit denotes NF-kappa B p65
T86 26-33 Nucleus denotes nuclear
T43 1513-1520 Nucleus denotes nuclear
T91 1534-1540 Peptide denotes signal
T93 1603-1606 ProteinSubunit denotes its
T95 1886-1893 Nucleus denotes nuclear
E1 115-122 NegativeRegulation denotes inhibit
E2 142-149 BindingOfProteinToDNA denotes binding
E3 245-252 BindingOfProteinToDNA denotes binding
E4 529-538 NegativeRegulation denotes inhibitor
E6 938-945 BindingOfProteinToDNA denotes binding
E7 957-965 RegulatoryProcess denotes mediated
E8 966-976 NegativeRegulation denotes inhibition
E9 992-999 PositiveRegulation denotes induced
E10 1008-1017 Transport denotes exclusion
E11 1186-1194 NegativeRegulation denotes inhibits
E14 1247-1255 RegulatoryProcess denotes mediated
E15 1352-1359 BindingToProtein denotes binding
E16 1414-1422 ProteinTargeting denotes retarget
E17 1689-1699 NegativeRegulation denotes attenuates
E18 1716-1728 Localization denotes localization
E19 1784-1792 RegulatoryProcess denotes mediated
E20 1793-1803 NegativeRegulation denotes inhibition
E21 1826-1842 BindingOfProteinToDNA denotes binding activity
E22 2136-2141 BindingToProtein denotes binds
E23 2175-2186 BindingToProtein denotes interaction
E24 2216-2227 ProteinTargeting denotes retargeting
E25 34-46 Localization denotes localization
E5 786-796 RegulatoryProcess denotes regulatory
E26 797-808 BindingToProtein denotes interaction
E12 1220-1246 PositiveRegulationOfTranscription denotes transcriptional activation
E13 1521-1533 Localization denotes localization
E27 1486-1494 Mutation denotes deletion
E28 1594-1602 NegativeRegulation denotes disrupts
E29 1618-1624 BindingToProtein denotes engage
E30 1894-1906 Localization denotes localization
R1 T1 T3 hasPart I kappa B/MAD-3,transactivation domain
R2 T8 T12 hasPart NF-kappa B,subunits
R5 T15 T16 encodes v-rel oncogene,product
R6 T18 T17 hasPart this complex,NF-kappa B p65
R8 T27 T26 fromSpecies NF-kappa B p65 mutants,human
R9 T46 T48 locatedIn kappa B enhancer,T lymphocytes
R10 T46 T45 fromSpecies kappa B enhancer,human immunodeficiency virus type 1
R11 T48 T47 fromSpecies T lymphocytes,human
R12 T60 T65 hasPart C-terminus,sequences
R13 T61 T60 hasPart NF-kappa B p65,C-terminus
R15 T73 T72 hasPart NF-kappa B p65,transactivation domain
R16 T75 T74 hasFunction I kappa B/MAD-3,inhibitory function
R18 T85 T84 hasPart NF-kappa B p65,domain
R3 E4 T19 locatedIn inhibitor,cytoplasmic
R4 T57 T91 hasPart homology domain,signal
R7 T58 T57 hasPart NF-kappa B p65,homology domain
R9 T3 E1 hasAgent transactivation domain,inhibit
R10 E2 E1 hasPatient binding,inhibit
R11 T5 E2 hasAgent NF-kappa B p65,binding
R12 T6 E2 hasPatient DNA,binding
R13 T12 E3 hasAgent subunits,binding
R14 T10 E3 hasPatient DNA,binding
R15 T21 E4 hasPatient NF-kappa B,inhibitor
R16 T28 E6 hasPatient DNA,binding
R17 T30 E7 hasAgent I kappa B,mediated
R18 E8 E7 hasPatient inhibition,mediated
R19 T33 E9 hasAgent I kappa B,induced
R20 E10 E9 hasPatient exclusion,induced
R21 T37 E10 hasPatient transcription factor,exclusion
R22 T39 E11 hasAgent I kappa B/MAD-3,inhibits
R23 E12 E11 hasPatient transcriptional activation,inhibits
R24 T46 E14 hasAgent kappa B enhancer,mediated
R25 E12 E14 hasPatient transcriptional activation,mediated
R26 T51 E15 hasPatient NF-kappa B p65,binding
R27 T50 E15 hasPatient I kappa B/MAD-3,binding
R28 E15 E16 hasAgent binding,retarget
R29 T53 E16 hasPatient NF-kappa B p65,retarget
R30 T60 E17 hasAgent C-terminus,attenuates
R31 E18 E17 hasPatient localization,attenuates
R32 T66 E19 hasAgent I kappa B,mediated
R33 E20 E19 hasPatient inhibition,mediated
R34 E21 E20 hasPatient binding activity,inhibition
R35 T69 E21 hasAgent NF-kappa B p65,binding activity
R36 T70 E21 hasPatient DNA,binding activity
R37 T78 E22 hasPatient NF-kappa B p50,binds
R38 T76 E22 hasPatient I kappa B/MAD-3,binds
R39 T81 E24 hasPatient NF-kappa B p50,retargeting
R40 T2 E25 hasPatient NF-kappa B p65,localization
R41 E26 E5 hasAgent interaction,regulatory
R42 T24 E26 hasPatient NF-kappa B,interaction
R43 T25 E26 hasPatient I kappa B/MAD-3,interaction
R44 T91 E27 hasPatient signal,deletion
R45 E27 E28 hasAgent deletion,disrupts
R46 E29 E28 hasPatient engage,disrupts
R47 T93 E29 hasPatient its,engage
R48 T59 E29 hasPatient I kappa B/MAD-3,engage
R49 T73 E30 hasPatient NF-kappa B p65,localization